Bacterial Ghosts of Pseudomonas aeruginosa as a Promising Candidate Vaccine and Its Application in Diabetic Rats.
Salah A SheweitaAmro Abd Al Fattah AmaraHeba GamalAmany A GhazyAhmed HusseinMohammed Bahey-El-DinPublished in: Vaccines (2022)
Infections with Pseudomonas   aeruginosa (PA) pose a major clinical threat worldwide especially to immunocompromised patients. As a novel vaccine network for many kinds of bacteria, bacterial ghosts (BGs) have recently been introduced. In the present research, using Sponge-Like Reduced Protocol , P. aeruginosa ghosts (PAGs) were prepared to maintain surface antigens and immunogenicity. This is the first study, to our knowledge, on the production of chemically induced well-structured bacterial ghosts for PA using concentrations of different chemicals. The research was carried out using diabetic rats who were orally immunized at two-week intervals with three doses of PAGs. Rats were subsequently challenged either by the oral route or by the model of ulcer infection with PA . In challenged rats, in addition to other immunological parameters, organ bioburden and wound healing were determined, respectively. Examination of the scanning and transmission electron microscope (EM) proved that PAGs with a proper three-dimensional structure were obtained. In contrast to control groups, oral PAGs promoted the generation of agglutinating antibodies, the development of IFN-γ, and the increase in phagocytic activity in vaccinated groups. Antibodies of the elicited PAGs were reactive to PA proteins and lipopolysaccharides. The defense against the PA challenge was observed in PAGs-immunized diabetic rats. The resulting PAGs in orally vaccinated diabetic rats were able to evoke unique humoral and cell-mediated immune responses and to defend them from the threat of skin wound infection. These results have positive implications for future studies on the PA vaccine.
Keyphrases
- diabetic rats
- oxidative stress
- immune response
- wound healing
- pseudomonas aeruginosa
- dendritic cells
- healthcare
- magnetic resonance
- end stage renal disease
- newly diagnosed
- clinical trial
- high resolution
- prognostic factors
- escherichia coli
- computed tomography
- mass spectrometry
- cell therapy
- bone marrow
- contrast enhanced
- solar cells
- acute respiratory distress syndrome
- study protocol
- extracorporeal membrane oxygenation
- innate immune